CD40 and neoplasm: We have previously demonstrated the therapeutic efficacy of an autologous whole tumor cell vaccine composed of irradiated entire tumor cells (rWTC) pulsed with mannan-BAM, TLR agonists, and anti-CD40 antibody (MBTA) (Fig. 1).